Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Knowledge of the epidemiology of invasive pneumococcal disease (IPD) will aid in planning the use of pneumococcal vaccines. A United Kingdom (UK)-based surveillance in England and Wales (1995-1997) of 11,528 individuals with IPD and a local enhanced surveillance in the Oxford (UK) area (1995-1999) have been analyzed. IPD has a high attack rate in children, with 37.1-48.1 cases per 100,000 infants <1 year old per year, and in older persons, with 21.2-36.2 cases per 100,000 persons >65 years old per year, for England, Wales, and Oxford. The 7-valent conjugate vaccine includes serotypes causing < or =79% of IPD in children <5 years old, but only 66% in adults >65 years old. The data also indicate that IPD varies by serotype, age, and country, emphasizing that the epidemiology of IPD is heterogeneous and requires continued surveillance.

Original publication

DOI

10.1086/317924

Type

Journal article

Journal

J Infect Dis

Publication Date

15/01/2001

Volume

183

Pages

239 - 246

Keywords

Adolescent, Adult, Age Distribution, Aged, Anti-Bacterial Agents, Child, Child, Preschool, Drug Resistance, Microbial, England, Female, Humans, Incidence, Infant, Male, Microbial Sensitivity Tests, Middle Aged, Pneumococcal Infections, Pneumococcal Vaccines, Serotyping, Streptococcus pneumoniae, Vaccination, Vaccines, Conjugate, Wales